Youcare Pharmaceutical's (SHA:688658) unit, Beijing Youcare Kechuang Pharmaceutical Technology, received approval from the U.S. Food and Drug Administration to proceed with the clinical trial of YKYY033 injection, according to a Shanghai bourse filing on Thursday.
The drug will be tested as a prevention and treatment for arterial and venous thrombosis.
The Chinese pharmaceutical company's shares rose 1% during the afternoon trade.